Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - ACCOUNTS PAYABLE
Accounts Payable NBIX - Neurocrine Biosciences, Inc.
110 M
LAST VALUE
27.85%
2 YEAR CAGR
21.58%
5 YEAR CAGR
84.10%
10 YEAR CAGR